Document is current

Article History

Received: 2 May 2025

Accepted: 24 June 2025

First Online: 7 August 2025

Declarations

:

: Lauren CS Kole has received consulting fees from Boehringer Ingelheim and participated in clinical trials for AbbVie and Ortho Dermatologics. Yayoi Tada has received honoraria and/or grants from AbbVie, Boehringer Ingelheim, Eisai, Eli Lilly, Janssen, Kyowa Kirin, LEO Pharma, Maruho, Mitsubishi Tanabe Pharma, Novartis, Sun Pharmaceutical Industries, Taiho Pharmaceutical, Torii Pharmaceutical, and UCB. Sascha Gerdes has acted as an advisor for, and/or has received speakers’ honoraria and/or grants from, and/or has participated in clinical trials for AbbVie, Adimune Inc, Affibody AB, Akari Therapeutics Plc, Almirall-Hermal, Amgen, Argenx BV, Aristea Therapeutics, Biogen Idec, Bioskin, Bristol Myers Squibb, Boehringer Ingelheim, Celgene, Dermira, Eli Lilly, Galderma, Hexal AG, Incyte Inc., Janssen-Cilag, Johnson & Johnson, Klinge Pharma, Kymab, LEO Pharma, Medac, MSD, Neubourg Skin Care GmbH, Novartis, Pfizer, Pierre Fabre, Principia Biopharma, Regeneron Pharmaceutical, Sandoz Biopharmaceuticals, Sanofi-Aventis, Trevi Therapeutics, and UCB. Alice B Gottlieb has received research/educational grants from Bristol Myers Squibb, Highlights Therapeutics, Janssen, and UCB Pharma (all paid to Mount Sinai School of Medicine until 2 May 2025); and received honoraria as an advisory board member and consultant from Amgen, AnaptysBio, Avotres Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Dice Therapeutics, Eli Lilly, Highlights Therapeutics, Janssen, Novartis, Sanofi, Teva, UCB, and Xbiotech (stock options for Rheumatoid Arthritis). Matthias Augustin has acted as a consultant and/or paid speaker, has received research grants and/or honoraria for consulting and/or scientific lectures, and/or received travel expense reimbursement and/or participated in clinical trials sponsored by companies that manufacture drugs used for the treatment of psoriasis, including AbbVie, Almirall, Amgen, Biogen Idec, Boehringer Ingelheim, Celgene, Centocor, Eli Lilly, Janssen-Cilag, LEO Pharma, MEDAC Pharma, Merck Sharp & Dohme, Mundipharma, Novartis, Pfizer, Pohl-Boskamp, Sandoz, and XenoPort. Min Zheng has participated in advisory boards and/or acted as an investigator and/or speaker for and received grants and/or honoraria from AbbVie, Janssen-Cilag, Boehringer Ingelheim, LEO Pharma China, Xian-Janssen, Novartis, and Pfizer Inc. Hideaki Miyachi has received speaker’s honoraria and/or consultant fees from companies that manufacture drugs used for the treatment of psoriasis, including AbbVie, Boehringer Ingelheim, Eli Lilly, Janssen, Kyowa Kirin, LEO Pharma, Maruho, Novartis, Sun Pharmaceutical Industries, Taiho Pharmaceutical, and UCB. Iris Chen-Yin Lai is a co-investigator for several vaccine trials carried out at National Taiwan University Children’s Hospital. S Renée Marshall, Smita Jha, and Ferhal Küçükosman are employees of Boehringer Ingelheim. Gang Wang has received honoraria and/or grants from AbbVie, Boehringer Ingelheim, Eli Lilly, Janssen, LEO Pharma, and Novartis Pharma.

: This study was conducted in accordance with the ethical principles of the Declaration of Helsinki of 1964 and its later amendments. Ethics committee approval was not required for this study. The research conducted (qualitative patient surveys and interviews) complied with local Data Protection Laws and the Market Research Society’s Code of Conduct, including ESOMAR, EphMRA and all other relevant national codes of practice. All patients provided written informed consent for participation in the study and the use of their de-identified, anonymized, aggregated data for publication.